A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.
暂无分享,去创建一个
P. Fitzgerald | A. Kirtane | M. Leon | S. Solomon | L. Mauri | J. Douglas | C. O'shaughnessy | D. Kandzari | J. Popma | D. Cutlip | E. Nikolsky | R. Caputo | Kweli P. Thompson | M. Ball | P. Overlie | Ash Jain | T. Tolleson | B. McLaurin | B. Reen